Brain Scientific(BRSF)
$0.750.00 (0.00%)
BRSF
Brain Scientific financials statements
$0.75
At close:0.00 (0.00%)
Brain Scientific (BRSF) Ratios
7 Followers
Brain Scientific Ratios
BRSF's free cash flow for Q4 2022 was $-1.25M. For the 2022 fiscal year, BRSF's free cash flow was decreased by $-5.83K and operating cash flow was $-1.24M. See a summary of the company’s cash flow.
| Ratios | Dec 22 | Mar 22 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.18 | 0.26 | 0.06 | 0.24 | 0.78 |
| Quick Ratio | 0.16 | 0.23 | 0.04 | 0.24 | 0.78 |
| Cash Ratio | 0.10 | 0.18 | 0.03 | 0.22 | 0.72 |
| Solvency Ratio | -1.55 | -0.63 | -1.25 | -0.84 | -6.09 |
| Operating Cash Flow Ratio | -0.80 | -1.35 | -0.44 | -0.72 | -4.90 |
| Short-Term Operating Cash Flow Coverage | -2.14 | -7.16 | -1.43 | -0.98 | -22.25 |
| Net Current Asset Value | $ -6.12M | $ -12.94M | $ -2.10M | $ -897.21K | $ -55.97K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.24 | 0.80 | 3.38 | 3.02 | 0.35 |
| Debt-to-Equity Ratio | 0.66 | -15.33 | -0.38 | -0.98 | -1.16 |
| Debt-to-Capital Ratio | 0.40 | 1.07 | -0.61 | -52.18 | 7.29 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 1.08 | -0.06 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.72 | -19.25 | -0.11 | -0.32 | -3.34 |
| Debt Service Coverage Ratio | -1.24 | -6.04 | -4.05 | -1.07 | -6.14 |
| Interest Coverage Ratio | -2.67 | -15.52 | -93.96 | -29.47 | -8.07 |
| Debt to Market Cap | 29.09 | 1.54 | 0.04 | 0.06 | 0.01 |
| Interest Debt Per Share | 6.79 | 31.05 | 2.51 | 4.03 | 1.51 |
| Net Debt to EBITDA | -0.27 | -1.19 | -0.25 | -0.64 | 0.08 |
| Profitability Margins | |||||
| Gross Profit Margin | 25.32% | 31.32% | 53.28% | 20.85% | 41.60% |
| EBIT Margin | -4072.67% | -3214.73% | -2956.83% | -198.32% | -2211.42% |
| EBITDA Margin | -3697.60% | -3132.01% | -2938.31% | -198.05% | -2210.29% |
| Operating Profit Margin | -4478.11% | -3257.41% | -2956.84% | -198.32% | -2211.42% |
| Pretax Profit Margin | -5753.00% | -3424.57% | -2992.64% | -204.75% | -2454.02% |
| Net Profit Margin | -5753.00% | -3424.57% | -2992.64% | -205.20% | -2454.02% |
| Continuous Operations Profit Margin | -5753.00% | -3424.57% | -2992.64% | -205.20% | -2454.02% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.22% | 100.00% |
| EBT Per EBIT | 128.47% | 105.13% | 101.21% | 103.24% | 110.97% |
| Return on Assets (ROA) | -105.11% | -68.04% | -1245.07% | -344.97% | -791.78% |
| Return on Equity (ROE) | -285.92% | 1309.58% | 139.62% | 112.10% | 2642.30% |
| Return on Capital Employed (ROCE) | -222.18% | -95.85% | 146.06% | 108.34% | 2741.47% |
| Return on Invested Capital (ROIC) | -133.81% | -86.95% | 222.25% | 5761.57% | -14983.33% |
| Return on Tangible Assets | -775.15% | -590.40% | -1245.07% | -344.97% | -791.78% |
| Earnings Yield | -12952.63% | -134.26% | -13.36% | -6.67% | -14.62% |
| Efficiency Ratios | |||||
| Receivables Turnover | 226.57 | 15.70 | 64.15 | 88.07 | 0.00 |
| Payables Turnover | 0.15 | 0.17 | 0.11 | 1.26 | 0.24 |
| Inventory Turnover | 1.07 | 1.25 | 0.97 | 0.00 | 0.00 |
| Fixed Asset Turnover | 1.02 | 0.84 | 1.02 | 292.24 | 29.07 |
| Asset Turnover | 0.02 | 0.02 | 0.42 | 1.68 | 0.32 |
| Working Capital Turnover Ratio | -0.05 | -0.10 | -0.06 | -1.03 | -0.12 |
| Cash Conversion Cycle | -2107.61 | -1886.44 | -2940.63 | -286.05 | -1501.74 |
| Days of Sales Outstanding | 1.61 | 23.24 | 5.69 | 4.14 | 0.00 |
| Days of Inventory Outstanding | 340.67 | 292.15 | 374.52 | 0.00 | 0.00 |
| Days of Payables Outstanding | 2449.89 | 2201.83 | 3320.84 | 290.20 | 1501.74 |
| Operating Cycle | 342.28 | 315.39 | 380.21 | 4.14 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -6.23 | -16.25 | -2.95 | -3.78 | -7.58 |
| Free Cash Flow Per Share | -6.26 | -16.42 | -3.05 | -3.78 | -7.59 |
| Dividend Paid and CapEx Coverage Ratio | -178.27 | -100.04 | -30.68 | -850.47 | -973.48 |
| Capital Expenditure Coverage Ratio | -178.27 | -100.04 | -30.68 | -850.47 | -973.48 |
| Operating Cash Flow Coverage Ratio | -2.07 | -0.55 | -1.22 | -0.97 | -17.79 |
| Operating Cash Flow to Sales Ratio | -27.66 | -22.08 | -9.95 | -1.75 | -19.15 |
| Free Cash Flow Yield | -6262.71% | -87.42% | -4.59% | -5.69% | -11.42% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.01 | -0.74 | -7.48 | -14.98 | -6.84 |
| Price-to-Sales (P/S) Ratio | 0.44 | 25.51 | 223.92 | 30.75 | 167.82 |
| Price-to-Book (P/B) Ratio | 0.02 | -9.75 | -10.45 | -16.80 | -180.70 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.02 | -1.14 | -21.80 | -17.58 | -8.76 |
| Price-to-Operating Cash Flow Ratio | -0.02 | -1.16 | -22.51 | -17.60 | -8.77 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.00 | -0.07 | 0.28 | -0.15 |
| Enterprise Value Multiple | -0.28 | -2.00 | -7.87 | -16.16 | -7.51 |
| Enterprise Value | 2.21M | 16.64M | 21.67M | 15.66M | 9.65M |
| EV to EBITDA | -0.28 | -2.00 | -7.87 | -16.16 | -7.51 |
| EV to Sales | 10.30 | 62.63 | 231.31 | 32.01 | 166.09 |
| EV to Free Cash Flow | -0.37 | -2.81 | -22.52 | -18.30 | -8.67 |
| EV to Operating Cash Flow | -0.37 | -2.84 | -23.25 | -18.32 | -8.67 |
| Tangible Book Value Per Share | -6.12 | -34.71 | -6.36 | -3.96 | -0.37 |
| Shareholders’ Equity Per Share | 4.53 | -1.93 | -6.36 | -3.96 | -0.37 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 |
| Revenue Per Share | 0.23 | 0.74 | 0.30 | 2.16 | 0.40 |
| Net Income Per Share | -12.95 | -25.21 | -8.88 | -4.44 | -9.72 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.41 | 1.07 | 1.01 | 1.03 | 1.11 |
| Research & Development to Revenue | 1.41 | 1.24 | 2.25 | 0.21 | 3.62 |
| SG&A to Revenue | 40.38 | 27.73 | 25.74 | 1.61 | 16.31 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 3.80 | 0.00 | 0.00 |
| Income Quality | 0.48 | 0.64 | 0.33 | 0.85 | 0.78 |
Currency in USD

